Research Article

Real-World Experience with Cangrelor as Adjuvant to Percutaneous Coronary Intervention: A Single-Centre Observational Study

Table 2

PCI procedure characteristics (n = 991).

PCI procedure priority
 Acute869 (87.7%)
 Subacute71 (7.2%)
 Elective51 (5.1%)
PCI procedure indication
 OHCA107 (10.8%)
 IHCA8 (0.8%)
 STEMI723 (73.0%)
 NSTEMI79 (8.0%)
 UAP9 (0.9%)
 SAP48 (4.8%)
 Arrhythmia6 (0.6%)
 Heart failure11 (1.1%)
Access site for PCI
 Radial520 (52.5%)
 Femoral467 (47.1%)
 Brachial4 (0.4%)
 Mechanical ventilation during procedure118 (11.9%)
 Vasopressors and/or inotropes during procedure109 (11.0%)
 Haemodynamic support in during procedure37 (3.7%)
 Impella19 (1.9%)
 VA-ECMO17 (1.7%)
 IABP1 (0.1%)
 Aspiration thrombectomy70 (7.1%)
Intervention
 Drug-eluting stent943 (95.2%)
 POBA (including DEB)42 (4.2%)
 No PCI (unsuccessful)6 (0.6%)
Number of stents
 048 (4.8%)
 1483 (48.7%)
 2241 (24.3%)
 3 or more219 (22.1%)

PCI: percutaneous coronary intervention; OHCA: out-of-hospital cardiac arrest; IHCA: in-hospital cardiac arrest; STEMI: ST-segment elevation myocardial infarction; NSTEMI: non-ST-segment elevation myocardial infarction; UAP: unstable angina pectoris; VA-ECMO: venoarterial extracorporeal membrane oxygenation; IABP: intra-aortic balloon pump.